The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Angiotensin II Potentiates Vascular Endothelial Growth Factor–Induced Angiogenic Activity in Retinal Microcapillary Endothelial Cells
Abstract
Abstract—Angiotensin II (Ang II) plays a role in the development of many vascular diseases. In the present study, we have investigated the effect of Ang II on vascular endothelial growth factor (VEGF) receptor expression and VEGF-induced angiogenic activity in bovine retinal microcapillary endothelial cells (BRECs). Ang II induced a significant increase of kinase domain–containing receptor/total liver kinase (KDR/Flk-1) mRNA in a time- and dose-dependent manner, with a maximal 4.3±0.8-fold increase after a 4-hour stimulation. Ang II increased the rate of KDR gene transcription by 5.4-fold, whereas the half-life of KDR mRNA was not increased significantly. The increase depended partially on new protein synthesis. The Ang II–induced KDR mRNA increase was inhibited by either [Sar 1,Ile 8]angiotensin or angiotensin type 1 receptor antagonists but was not significantly altered by angiotensin type 2 receptor antagonists. The PKC inhibitor reduced Ang II–induced KDR mRNA expression by 70±15%. The tyrosine kinase inhibitor reduced the Ang II– and phorbol 12-myristate 13-acetate–induced KDR mRNA increases by 35±8% and 44±26%, respectively. Ang II increased by 3.1-fold the 35 S-labeled KDR/Flk-1 immunoprecipitated by a specific antibody to KDR/Flk-1. Scatchard analysis demonstrated that Ang II induced a significant increase of binding sites without changing binding affinity. Ang II enhanced VEGF-induced cell growth and tube formation. Ang II itself had no effect on cell growth, tube formation, or mRNA levels of VEGF and tms-like tyrosine kinase (Flt-1) in BRECs. These findings suggest that Ang II might potentiate VEGF-induced angiogenic activity through an increase of the VEGF receptor KDR/Flk-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
Liang, P., & Pardee, A. B. (1992) · Science · doi:10.1126/science.1354393 · Cited by 4,984
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931 · cited 1×
“experiments also suggest differences of these receptor functions in the development of the vascular system.(12,13) VEGF does not”
BackgroundAiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606 · cited 1×
“experiments also suggest differences of these receptor functions in the development of the vascular system.(12,13) VEGF does not”
BackgroundPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Self-citationInhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906
Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1535 · Cited by 835
Identification of angiotensin II receptor subtypes
Chiu, A. T., Herblin, W. F., McCall, D. E., Ardecky, R. J., Carini, D. J., Duncia, J. V., Pease, L. J., Wong, P. C., Wexler, R. R., Johnson, A. L., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91054-1 · Cited by 819
Preliminary biochemical characterization of two angiotensin II receptor subtypes
Whitebread, S., Mele, M., Kamber, B., & de Gasparo, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92133-5 · Cited by 777
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Nakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10663 · Cited by 680
Gibbons, G. H., Pratt, R. E., & Dzau, V. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115881 · Cited by 645
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., Nogami, A., Murumo, F., & Hiroe, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116579 · Cited by 573
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566
Self-citationExpression of AT2 receptors in the developing rat fetus.
Grady, E. F., Sechi, L. A., Griffin, C. A., Schambelan, M., & Kalinyak, J. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115395 · Cited by 535
Tolentino, M. J., Miller, J. W., Gragoudas, E. S., Jakobiec, F. A., Flynn, E., Chatzstefanou, K., Ferrara, N., & Adamis, A. P. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30420-x · Cited by 518
Aliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463
Goto, F., Goto, K., Weindel, K., & Folkman, J. (1993) · PubMed · Cited by 459
King, G. L., Goodman, A. D., Buzney, S., Moses, A., & Kahn, C. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111764 · Cited by 437
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Lopez, A., & Marantz, P. R. (1994) · PubMed · Cited by 424
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00521.x · Cited by 423
Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.
Imai, T., Hirata, Y., Emori, T., Yanagisawa, M., Masaki, T., & Marumo, F. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.753 · Cited by 359
Amin, R. H., Frank, R. N., Kennedy, A., Eliott, D., Puklin, J. E., & Abrams, G. W. (1997) · PubMed · Cited by 354
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Brock, T. A., Dvorak, H. F., & Senger, D. R. (1991) · PubMed · Cited by 321
Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.913 · Cited by 301
DANSER, A. H. J., VAN DEN DORPEL, M. A., DEINUM, J., DERKX, F. H. M., FRANKEN, A. A. M., PEPERKAMP, E., DE JONG, P. T. V. M., & SCHALEKAMP, M. A. D. H. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-160 · Cited by 281
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 255
Simonson, M. S., & Herman, W. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98357-2 · Cited by 223
Angiotensin levels in the eye.
Danser, A. H. J., Derkx, F. H. M., Admiraal, P. J., Deinum, J., de Jong, P. T. V. M., & Schalekamp, M. A. D. H. (1994) · PubMed · Cited by 218
Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
Dzau, V. J., Gibbons, G. H., & Pratt, R. E. (1991) · Hypertension · doi:10.1161/01.hyp.18.4_suppl.ii100 · Cited by 191
Doria, A., Warram, J. H., & Krolewski, A. S. (1994) · Diabetes · doi:10.2337/diab.43.5.690 · Cited by 191
Millan, M. A., Jacobowitz, D. M., Aguilera, G., & Catt, K. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11440 · Cited by 182
Patterson, C., Perrella, M. A., Endege, W. O., Yoshizumi, M., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118816 · Cited by 169
Patterson, C., Perrella, M. A., Hsieh, C.-M., Yoshizumi, M., Lee, M.-E., & Haber, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23111 · Cited by 167
Takagi, H., King, G. L., & Aiello, L. P. (1996) · Diabetes · doi:10.2337/diab.45.8.1016 · Cited by 110
Self-citationAn ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen.
Sramek, S. J., Wallow, I. H. L., Tewksbury, D. A., Brandt, C. R., & Poulsen, G. L. (1992) · PubMed · Cited by 78
Serum Angiotensin Converting Enzyme in Diabetic Patients
Feman, S. S., Mericle, R. A., Reed, G. W., et al. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199305000-00002 · Cited by 34
Leitersdorf, E., Stein, O. T., & Stein, Y. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90272-3 · Cited by 28
Cited by
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor
Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jüpner, A., Baur, E., Nissen, E., Vetter, K., Neichel, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4106 · Cited by 826
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Oh, H., Takagi, H., Suzuma, K., Otani, A., Matsumura, M., & Honda, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15732 · Cited by 499
Self-citation
Metadata
- Authors
- Otani, A., Takagi, H., Suzuma, K., & Honda, Y.
- Venue
- Circulation Research
- Published
- 1998-03-23
- Volume
- 82
- Issue
- 5
- Pages
- 619-628
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1989049255
- Cited by
- 266
- References
- 52
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.